Pharmacytimes: Condition Center: COPD
COPDen-usWed, 21 Feb 2018 06:38:42 UTCWed, 21 Feb 2018 06:38:42 UTCManagement of Community-Acquired Pneumonia in Adults
Here is an overview of the key Issues for hospital pharmacists.5:20 PM, Mon January 15, 2018FDA OKs First Nebulized LAMA COPD Treatment
The FDA has approved glycopyrrolate (Lonhala Magnair, Sunovion) inhalation solution, also known as SUN-101/eFlow, the first nebulized long-acting muscarinic antagonist (LAMA) for the treatment of chronic obstructive pulmonary disease (COPD).<br />
8:00 AM, Thu December 7, 2017Trelegy Ellipta for COPD: What Pharmacists Should Know
The medication is indicated for the long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease.4:08 AM, Mon December 4, 2017COPD: Delving Into Inhaler Adherence
Chronic obstructive pulmonary disease (COPD)—irreversible—requires long-term adherence to pharmacotherapies for best outcomes.12:05 PM, Wed November 22, 2017Express Scripts and Propeller Health Bringing Smart Inhalers to Market
Does this represent an opportunity for pharmacists to use such devices to help monitor adherence in patients?11:58 PM, Sun November 19, 2017Long-acting Medication Use in COPD: Opportunities for Minimizing Medication Waste in the Hospital Setting
9:47 AM, Wed November 1, 2017FDA Approves First Once-Daily Single Inhaler Triple Therapy for COPD
Officials with the FDA have approved fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) (Trelegy Ellipta, GlaxoSmithKline and Innoviva), for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).1:12 PM, Tue September 19, 2017Influenza vs. the Common Cold: Which One Is It?
The thing is, you still may get sick after getting the flu because there are other things such as the common cold that might cross your path. 9:54 PM, Thu August 24, 2017Global Burden of Disease: Asthma and COPD
The prevalence of lung conditions worldwide has increased, despite the overall decrease in the prevalence and death rates for asthma between 1990 and 2015, according to the results of the 2015 Global Burden of Disease (GBD) Study.11:20 AM, Thu August 17, 2017Backing Up: Addressing Adherence Barriers in COPD
Patients with chronic obstructive pulmonary disease (COPD) often have difficulty adhering to medications, leading to exacerbations, and often hospitalization.10:26 AM, Mon August 7, 2017How Can Pharmacists Improve Flu Vaccination Rates in Patients with COPD?
Pharmacists can play a crucial role in promoting the flu vaccine to these patients by recognizing the characteristics of those who do not seek vaccinations.10:52 AM, Wed August 2, 2017Chronic Obstructive Pulmonary Disease in Hospitalized Patients: Managing Exacerbations
5:08 AM, Fri May 19, 2017Physical Activity Reduces Anxiety and Depression Risk in Patients With COPD
<p>The study, presented at the European Respiratory Society International Congress in London, analyzed data on 409 patients with COPD from primary care practices in the Netherlands and Switzerland.</p>
3:49 PM, Thu April 20, 20175 COPD Studies Every Pharmacist Should Know
Over the years, a number of landmark clinical studies on COPD have been published, shaping how we treat the disease today.10:12 PM, Sun April 2, 2017Withdrawal of Inhaled Corticosteroids in Patients with Stable Chronic Obstructive Pulmonary Disease
COPD is the fourth leading cause of death in the United States, contributing to more than 120,000 deaths each year.1:50 AM, Fri September 23, 2016Bevespi Aerosphere
The FDA has approved bevespi aerosphere inhalation aerosol for the long-term maintenance treatment of airflow obstruction in patients with COPD.4:10 AM, Fri September 16, 2016Stiff Competition to Create a Smarter Inhaler
3M Drug Delivery Systems will be working to introduce its Intelligent Inhaler to the market by developing a partnership with pharmaceutical companies.11:14 PM, Sun July 10, 2016New COPD Maintenance Treatment Approved
The FDA has approved AstraZeneca's glycopyrrolate and formoterol fumarate (Bevespi Aerosphere) inhalation aerosol for long-term maintenance treatment for patients with chronic obstructive pulmonary disease.
7:00 AM, Mon May 2, 2016Utibron Neohaler
The FDA has approved Utibron Neohaler oral inhalation powder for long-term maintenance treatment of airflow obstruction in patients with COPD. 1:20 AM, Fri April 8, 2016Why Are COPD Patients Afraid to Exercise?
Patients with chronic obstructive pulmonary disease have reductions in their brains' gray matter related to the processing of dyspnea, fear, and sensitivity to painful stimuli.
10:12 PM, Wed March 30, 2016